Innovating Broad Protection Through T-Cell Activation
AI Speeds Discovery of Broad-Spectrum Coronavirus Vaccine
Researchers at UC Irvine use AI to design vaccines that target T cells for protection against multiple viruses.
3D medical illustration of a digital neural network interface overlaying a model of a coronavirus particle in a high-tech laboratory setting.
Photo: Avantgarde News
A research team at the University of California, Irvine, has designed a new broad-spectrum coronavirus vaccine using artificial intelligence [1]. Led by Dr. Lbachir BenMohamed, the project aims to provide protection against several viruses within the coronavirus family, including SARS-CoV-2 and MERS [1]. This AI-aided discovery represents a significant shift in how scientists approach viral immunity [2].
Unlike traditional vaccines that often focus on surface proteins, this design focuses on activating T cells [1]. These cells can recognize and destroy infected cells across different virus strains [1]. Researchers believe this approach could lead to a more resilient defense against future viral outbreaks by targeting parts of the virus that do not change as frequently [1][2].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
The source list contains only two independent domains, which is below the recommended threshold of three.
Sources
Related stories
View all
Topics
About the author
Avantgarde News Desk covers innovating broad protection through t-cell activation and editorial analysis for Avantgarde News.